RVNC

Revance Therapeutics Inc

Halal Rating :
Uncomfortable
See Details
Last Price $4.17 Last updated:
Market Cap -
7D Change 12.7%
1 Year Change -39.74%

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange
Next Earnings Date

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $59.88m $98.87m - $6.73m 0.00% 6.81%
June 30, 2024 $65.39m $105.58m - $5.68m 0.00% 5.38%
March 31, 2024 $51.94m $104.02m - $5.26m 0.00% 5.05%

Company Impact

Help us evaluate Revance Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates